Paulson & Co. - SALIX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Paulson & Co. ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$950,455,000
+42.4%
5,500,000
-5.3%
4.84%
+40.4%
Q4 2014$667,342,0005,806,0003.45%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Verition Fund Management LLC 2,787,800$481,760,00055.98%
Brenner West Capital Advisors 1,800,000$311,058,00028.01%
FNY Managed Accounts LLC 180,357$31,167,493,00025.70%
Twin Securities, Inc. 1,189,192$205,505,00024.16%
FIRST NEW YORK SECURITIES LLC /NY 98,099$16,952,488,00016.70%
HARVEST MANAGEMENT LLC 77,500$13,393,00014.40%
Tyrus Capital S.A.M. 687,800$118,859,00013.24%
BARDIN HILL MANAGEMENT PARTNERS LP 472,550$81,661,00011.65%
ARGENTIERE CAPITAL AG 151,500$26,181,00010.81%
Sachem Head Capital 725,000$125,425,0008.31%
View complete list of SALIX PHARMACEUTICALS INC shareholders